Skip to main content

Amy Mottl, MD, MPH, FASN

Associate Professor of Medicine, Division of Nephrology and Hypertension

Specialty Areas

Epidemiology and Pathogenesis of Diabetic Kidney Disease; Nephrotic Syndrome, Genetic and Cystic Diseases of the Kidney

Education and Experience

BS Summa Cum Laude: Northeastern University, 1993; MD Alpha Omega Alpha: Albert Einstein College of Medicine, 1999; Intern/Resident: University of North Carolina, 1999-2002; Nephrology Fellow: University of North Carolina, 2002-2005; MPH in Epidemiology UNC School of Public Health 2006; Clinical Instructor: University of North Carolina, 2005-2007; Clinical Assistant Professor of Medicine: 2007-2012; Medical Director: Fresenius Dialysis Center of Mebane, NC, 2012-2018; Associate Professor of Medicine: University of North Carolina, 2012-present.

Research and Clinical Interests

Dr. Mottl’s clinical interests include the multidisciplinary care, education and health equity for patients with diabetic kidney disease (DKD), genetic and glomerular kidney diseases. She focuses on collaboration with primary care providers and subspecialists to deliver patient centered, guideline driven care, expanding access to medications with cardiorenal benefits for patients with chronic kidney disease (CKD) as well as medical weight loss therapies. In addition to her clinic for DKD, vasculitis and glomerulonephritis, she has experience caring for patients with Fabry Disease and Autosomal Dominant Polycystic Kidney Disease. Her research interests include the epidemiology, pathogenesis and treatment of DKD and other glomerular diseases. She’s been an investigator of the SEARCH for Diabetes in Youth Study, a longitudinal cohort study of youth-onset type 1 and type 2 diabetes and its complications, for over 10 years. She is an investigator of TRIDENT, a longitudinal study of patients with DKD undergoing clinical biopsy and the Cure-Glomerulopathy Network, a study of the natural history, pathogenesis and treatment of glomerular disease, and has an R01 ancillary study to CureGN to study the intersection of diabetes in the setting of glomerular disease. She also has expertise in genetic epidemiology and is a co-investigator for the PAGE Study to identify genetic, metabolomic and epigenetic associations with kidney disease in diverse populations.

View list of publications on PubMed.